| Trial ID: | L0416 |
| Source ID: | ChiCTR2000036225
|
| Associated Drug: |
Qinghua Decoction
|
| Title: |
Clinical Study on Qinghua Decoction to Reduce the Risk of Coronary Artery Disease in Patients with NAFLD with Turbid Phlegm and Internal Resistance
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic fatty liver disease
|
| Interventions: |
Intervention Group:Qinghua Decoction+basic treatment;Control group:Basic treatment;
|
| Outcome Measures: |
Fibroscan;Liver ultrasound;Carotid ultrasound;Retinol binding protein 4;Cyclophilin A;Insulin Growth Factor-1;Alanine aminotransferase;Aspartate aminotransferase;Glutamyl transpeptidase;Triglycerides;Total cholesterol;Total bilirubin;Low-density lipoprotein;Fasting blood glucose;Fasting insulin;Insulin resistance index;TCM clinical efficacy index;Body Mass Index;Waist-to-Hip Ratio;
|
| Sponsor/Collaborators: |
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
|
| Gender: |
All
|
| Age: |
4075
|
| Phases: |
Phase 0
|
| Enrollment: |
Intervention Group:40;Control group:40;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Parallel
|
| Start Date: |
22/08/2020
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
7 September 2020
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=59327
|
